EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSOSIG00000005824
Gene Symbol: DHCR24
1 Cross references
207 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSOSIG00000018056
Gene Symbol: HMGCR
1 Cross references
195 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase B

Ensembl ID : ENSOSIG00000023419
Gene Symbol: HMGCRB
1 Cross references
205 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1b

Ensembl ID : ENSOSIG00000009420
Gene Symbol: PDPK1B
1 Cross references
221 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase B

Ensembl ID : ENSOSIG00000015554
Gene Symbol: HPDB
1 Cross references
204 Possible Orthologues:

5'-Nucleotidase Ecto

Ensembl ID : ENSOSIG00000018543
Gene Symbol: NT5E
1 Cross references
215 Possible Orthologues:

5'-Nucleotidase, Ecto (Cd73)

Ensembl ID : ENSOSIG00000020015
Gene Symbol: NT5E
1 Cross references
180 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 1a B

Ensembl ID : ENSOSIG00000015838
Gene Symbol: HTR1AB
1 Cross references
137 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 2c, G Protein-Coupled-Like 1

Ensembl ID : ENSOSIG00000006796
Gene Symbol: HTR2CL1
1 Cross references
201 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 5a, Genome Duplicate B

Ensembl ID : ENSOSIG00000005237
Gene Symbol: HTR5AB
1 Cross references
209 Possible Orthologues:

5-Hydroxytryptamine Receptor 1b

Ensembl ID : ENSOSIG00000020026
Gene Symbol: HTR1B
1 Cross references
181 Possible Orthologues:

5-Hydroxytryptamine Receptor 1b

Ensembl ID : ENSOSIG00000017168
Gene Symbol: HTR1B
1 Cross references
182 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).